View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
April 18, 1994


By CBR Staff Writer

Intel Corp says it has not ruled out taking IBM Corp to court over its plans to fabricate Cyrix Corp microprocessors and market them under its own name – Intel believes Cyrix does not have the right to manufacture chips at IBM’s facilities the its cross-licensing agreement with IBM, which does not allow for third-party manufacturing, but IBM said its lawyers thoroughly studied the issue and satisfied themselves that it will not have any bearing on the IBM-Cyrix agreement: a federal judge in Texas is expected to rule this summer on whether a company with an Intel patent cross-licence – such as IBM or SGS Thomson Microelectronics BV (see front) – can also make unauthorised Intel-like chips for Cyrix; IBM also has been in discussions to make the Pentium-like chip designed by NexGen Microsystems Inc, and says those talks are continuing; under IBM’s deal with Cyrix, it can derive standard cells from the parts – such as the iAPX-86 core that will go into the PowerPC 615.

Content from our partners
Green for go: Transforming trade in the UK
Manufacturers are switching to personalised customer experience amid fierce competition
How many ends in end-to-end service orchestration?

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.